HomeMBRX • NASDAQ
Moleculin Biotech Inc
add
$0.87
4.80%
After Hours:(0.057%)-0.00050
$0.87
Closed: Apr 17, 7:50:17 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.64M | -25.52% |
Net income | -1.88M | 81.67% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -6.61M | 25.57% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.28M | -81.83% |
Total assets | 16.93M | -55.71% |
Total liabilities | 10.95M | -9.86% |
Total equity | 5.98M | — |
Shares outstanding | 14.00M | — |
Price to book | 0.52 | — |
Return on assets | -82.38% | — |
Return on capital | -229.99% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.88M | 81.67% |
Cash from operations | -5.08M | -3.80% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 1.00K | -99.97% |
Net change in cash | -5.13M | -398.25% |
Free cash flow | -2.53M | -46.11% |
Previous close
$0.92
Day range
$0.85 - $0.94
Year range
$0.40 - $5.47
Market cap
12.24M USD
Avg Volume
563.99K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2015
Headquarters
Website
Employees
17
